Genotype predictors of response to asthma medications

Current Opinion in Pulmonary Medicine

Volumn 8, Issue 1, 2002, Pages 9-15

  Joos, L ^a   Sandford, A J ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEUKOTRIENE C4 SYNTHASE; STEROID;

ARACHIDONIC ACID METABOLISM; ASTHMA; DNA POLYMORPHISM; DRUG METABOLISM; GENETIC LINKAGE; GENOTYPE; HUMAN; PHARMACOGENETICS; REVIEW;

EID: 0036134989     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200201000-00003     Document Type: Review

References (59)

1. Genetics of asthma and allergic disease
2. Polymorphisms in candidate asthma genes
3. Turning off the signal: Desensitization of β-adrenergic receptor function
4. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
5. Genetic susceptibility to asthma: Bronchial hyperresponsiveness coinherited with a major gene for atopy
6. Genome-wide search for asthma susceptibility loci in a founder population
7. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma
8. 2-adrenergic receptor in normal and asthmatic subjects
9. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
10. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells
11. 2-adrenoceptor on desensitization in human lung mast cells
12. 2-adrenergic receptor gene and desensitization in human airway smooth muscle
13. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor
14. 2-adrenergic receptor polymorphism expressed in transgenic mice
15. A biallelic DNA polymorphism of the human beta-2-adrenergic receptor detected by Ban I-Adrbr-2
16. 2 adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma
17. 2 adrenergic receptor mRNA inhibits receptor synthesis
18. 2-adrenergic receptor regulate receptor expression
19. 2-adrenergic receptor gene
20. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
21. 2 adrenoceptor with reported childhood asthma: Population based study
22. 2-adrenergic receptor in nocturnal and nonnocturnal asthma: Evidence that Gly 16 correlates with the nocturnal phenotype
23. 2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma
24. 2-adrenergic receptor polymorphisms with severe asthma
25. 2-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites
26. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families
27. 2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population
28. 2-adrenocepter (ADRB2) haplotypes: A population study
29. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects
30. 2-receptor genotype
31. 2-adrenoreceptor gene are associated with decreased airway responsiveness
32. 2-adrenorecepter variants with bronchial hyperresponsiveness
33. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing
34. 2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics
35. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics
36. 2-adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics
37. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics
38. 2-adrenoceptor genotype
39. 2-adrenoceptor polymorphism
40. 2-agonist therapy
41. 2-adrenoceptors in asthmatic patients
42. 2-adrenergic receptor on the response to regular use of albuterol in asthma
43. 2-adrenoceptor polymorphism
44. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription
45. Genetic determinants of 5-lipoxygenase transcription
46. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
47. Characterization of the human cysteinyl leukotriene CysLT1 receptor
48. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
49. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma
50. 4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
51. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance
52. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma
53. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo
54. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects
55. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects: Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction
56. 3 receptor genes in normal and asthmatic subjects
57. Relation of theophylline clearance to oral dosage in children with chronic asthma
58. Pharmacokinetics of theophylline in children with asthma
59. Polymorphism of the ophylline metabolism in man